CDDF Annual Conference 2025

The CDDF Annual Conference addresses highly relevant topics in the development of anti-cancer drugs, fostering constructive discussions among leading experts from diverse fields central to oncology drug development. These include patient advocates, regulators from the FDA, EMA, and EU national agencies, health technology assessors, academic researchers, and the pharmaceutical industry.

This year’s programme will delve into key efforts to enhance diversity and inclusion in clinical trials, alongside the latest discussions on endpoints in oncology drug development. Attendees will benefit from expert presentations and panel discussions covering innovative clinical trial designs and tackling controversial topics in diagnostics.

Additionally, the conference will review the EU health technology assessment process, with a focus on addressing inequalities, exploring joint EMA/HTA scientific advice, and promoting patient participation.

Dates: 3–5 February 2025
Location: Noordwijk ann Zee, Netherlands